KR950023648A - Polypeptides Showing Biological Activity - Google Patents
Polypeptides Showing Biological Activity Download PDFInfo
- Publication number
- KR950023648A KR950023648A KR1019940000222A KR19940000222A KR950023648A KR 950023648 A KR950023648 A KR 950023648A KR 1019940000222 A KR1019940000222 A KR 1019940000222A KR 19940000222 A KR19940000222 A KR 19940000222A KR 950023648 A KR950023648 A KR 950023648A
- Authority
- KR
- South Korea
- Prior art keywords
- biological activity
- polypeptide
- short letter
- amino acid
- showing biological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
하기식(I)로 나타내어지는 폴리펩티드는 생물학적 활성이 매우 높고 다양한 범위의 미생물에 대하여 생물학적 활성을 나타내며, 이와 동시에 인테내의 적혈구의 파괴를 일으키지 않고 세포내에서 분해될 경우에도 부작용이 적은 특성을 갖는 우수한 폴리펩티드로서, 질병치료제, 식품첨가제 등의 다양한 용도에 사용될 수 있는 폴리펩티드이다.The polypeptide represented by the following formula (I) has a very high biological activity and exhibits biological activity against a wide range of microorganisms, and at the same time has excellent properties with little side effects even when degraded in cells without causing destruction of red blood cells in the inte. As a polypeptide, it is a polypeptide which can be used for various uses, such as a disease therapeutic agent and a food additive.
[상기식(I)에서 단문자는 아미노산의 단문자 약어이며, X는 아미노산 중 N 또는 T인 것이 바람직하다.][In the above formula (I), a short letter is a short letter abbreviation of an amino acid, and X is preferably N or T among amino acids.]
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
제1(A)도는 겔 여과하여 분리한 단백질들의 컬럼 용출 분포를 나타내는 그래프이고,1 (A) is a graph showing the column elution distribution of the proteins separated by gel filtration,
제1(B)도는 본 발명의 생물학적 활성을 나타내는 물질의 전기영동 결과를 나타내는 사진이고,1 (B) is a photograph showing the results of electrophoresis of the material exhibiting the biological activity of the present invention,
제2(A)도는 HPLC하여 얻은 용출결과를 나타내는 그래프이고,Figure 2 (A) is a graph showing the elution results obtained by HPLC,
제2(B)도는 HPLC하여 얻은 분획들의 활성도를 스타피로코코스아우레우스를 대상으로 측정한 결과를 나타내는 사진이고,FIG. 2 (B) is a photograph showing the results of measuring the activity of the fractions obtained by HPLC with respect to Staphylococcus aureus,
제3(A)도는 본 발명의 생물학적 활성을 나타내는 물질을 투여하기 전의 아메바 프로테우스의 사진이고,FIG. 3 (A) is a photograph of Amoeba proteus before administration of a substance exhibiting the biological activity of the present invention,
제3(B)도는 본 발명의 생물학적 활성을 나타내는 물질을 투여한 후의 아메바 프로테우스의 사진이다.Figure 3 (B) is a photograph of Amoeba proteus after administration of a substance exhibiting the biological activity of the present invention.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940000222A KR100252624B1 (en) | 1994-01-07 | 1994-01-07 | Polypeptide having biological activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940000222A KR100252624B1 (en) | 1994-01-07 | 1994-01-07 | Polypeptide having biological activity |
Publications (2)
Publication Number | Publication Date |
---|---|
KR950023648A true KR950023648A (en) | 1995-08-18 |
KR100252624B1 KR100252624B1 (en) | 2000-05-01 |
Family
ID=19375389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940000222A KR100252624B1 (en) | 1994-01-07 | 1994-01-07 | Polypeptide having biological activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100252624B1 (en) |
-
1994
- 1994-01-07 KR KR1019940000222A patent/KR100252624B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100252624B1 (en) | 2000-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Herrick et al. | Purification and physical characterization of nucleic acid helix-unwinding proteins from calf thymus. | |
DE69230670D1 (en) | COMPOSITIONS CONTAINING A BLOOD CLOTH POLYMER MATRIX FOR THE ADMINISTRATION OF OSTEOGENIC PROTEINS | |
ATE408699T1 (en) | ADMINISTRATION OF NUCLEIC ACIDS AND PROTEINS TO CELLS | |
KR900700618A (en) | Interleukin-1 Inhibitors | |
IS5087A (en) | Stable liquid interferon preparations | |
DE3681243D1 (en) | STABLE FORMULATION OF BIOLOGICALLY ACTIVE PROTEINS FOR PARENTERAL INJECTION. | |
KR960016889A (en) | Brain function improvers | |
DK0447585T4 (en) | Process for the preparation of an intravenously tolerant immunoglobulin G preparation | |
NL970008I1 (en) | Derivative of a tissue plasminogen activator. | |
KR890000517A (en) | Hybrid protein C and preparation method thereof | |
Horst et al. | The active components of crotoxin | |
DE69132545D1 (en) | Protein with cytokine activity, recombinant DNA, expression vector and host cells for its production | |
BR0013638A (en) | New interferon beta-like molecules | |
ES2060100T3 (en) | MICROPROTEINS, PREPARATION PROCEDURE, AND MEDICATION APPLICATION OF THESE PROTEINS. | |
CA2208274A1 (en) | Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes | |
DE68925275D1 (en) | ENDOTOXIN BINDING PROTEIN AND THEIR USE | |
RU94044534A (en) | Thiazole amino derivatives, processes for preparation thereof and pharmaceutical compositions containing said derivatives | |
ATE88500T1 (en) | DNA SEQUENCES CODING FOR PROTEINS WITH THE BIOLOGICAL ACTIVITY OF THE HUSI-TYPE INHIBITORS, GENETIC METHODS FOR THE PRODUCTION OF THESE PROTEINS, AND PHARMACEUTICALS CONTAINING THESE PROTEINS. | |
SE8005498L (en) | HOMOGENT FIBROBLAST INTERFERENCE AND PREPARATION OF IT | |
DE3881023D1 (en) | PROTEINS, EXPRESSION VECTORS, CONTAINING DNA ENCODING SUCH PROTEINS, AND CELLS CONTAINING SUCH EXPRESSION VECTORS. | |
KR900005994A (en) | Pharmaceutical preparations for the treatment of diseases caused by thrombocytopenia or thrombocytopenia | |
KR950023648A (en) | Polypeptides Showing Biological Activity | |
KR950023647A (en) | Polypeptides Showing Biological Activity | |
CA2139518A1 (en) | Antigenic regions of tlp complexes and antibodies against the same | |
KR920018076A (en) | New polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20060117 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |